Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 471

1.

Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.

Cherner M, Ellis RJ, Lazzaretto D, Young C, Mindt MR, Atkinson JH, Grant I, Heaton RK; HIV Neurobehavioral Research Center Group.

AIDS. 2004 Jan 1;18 Suppl 1:S27-34.

PMID:
15075495
2.

HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.

Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD.

AIDS. 2007 Jul 11;21(11):1415-22.

PMID:
17589187
3.

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.

Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I; HNRC Group.

AIDS. 2005 Oct;19 Suppl 3:S72-8.

PMID:
16251831
4.

Cognitive functioning in younger and older HIV-1-infected adults.

Wilkie FL, Goodkin K, Khamis I, van Zuilen MH, Lee D, Lecusay R, Concha M, Symes S, Suarez P, Eisdorfer C.

J Acquir Immune Defic Syndr. 2003 Jun 1;33 Suppl 2:S93-S105.

PMID:
12853858
5.

Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.

Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, Chua P, Judd F.

HIV Med. 2006 Mar;7(2):112-21.

6.

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.

Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA.

Ann Neurol. 1997 Nov;42(5):679-88.

PMID:
9392566
7.

Prevalence of cognitive disorders differs as a function of age in HIV virus infection.

Becker JT, Lopez OL, Dew MA, Aizenstein HJ.

AIDS. 2004 Jan 1;18 Suppl 1:S11-8.

PMID:
15075493
8.

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J.

AIDS. 1998 May 28;12(8):F65-70.

PMID:
9631133
9.

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I.

Arch Neurol. 2002 Jun;59(6):923-8.

PMID:
12056927
10.

Older age and plasma viral load in HIV-1 infection.

Goodkin K, Shapshak P, Asthana D, Zheng W, Concha M, Wilkie FL, Molina R, Lee D, Suarez P, Symes S, Khamis I.

AIDS. 2004 Jan 1;18 Suppl 1:S87-98.

PMID:
15075503
11.

Neurocognitive symptoms and impairment in an HIV community clinic.

Kim DH, Jewison DL, Milner GR, Rourke SB, Gill MJ, Power C.

Can J Neurol Sci. 2001 Aug;28(3):228-31.

PMID:
11513341
12.

Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center.

Plummer DJ, Marcotte TD, Sample PA, Wolfson T, Heaton RK, Grant I, Freeman WR.

Invest Ophthalmol Vis Sci. 1999 Feb;40(2):435-42.

PMID:
9950603
13.

Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study.

Justice AC, McGinnis KA, Atkinson JH, Heaton RK, Young C, Sadek J, Madenwald T, Becker JT, Conigliaro J, Brown ST, Rimland D, Crystal S, Simberkoff M; Veterans Aging Cohort 5-Site Study Project Team.

AIDS. 2004 Jan 1;18 Suppl 1:S49-59.

PMID:
15075498
14.

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, Marder K.

Neurology. 2004 Dec 14;63(11):2084-90.

PMID:
15596754
15.

The relationship between plasma viral load and neuropsychological functioning in HIV-1 infection.

Reger MA, Martin DJ, Cole SL, Strauss G.

Arch Clin Neuropsychol. 2005 Mar;20(2):137-43.

16.

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.

Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):56-63. Erratum in: J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):529.

PMID:
19731418
17.

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.

McCutchan JA, Wu JW, Robertson K, Koletar SL, Ellis RJ, Cohn S, Taylor M, Woods S, Heaton R, Currier J, Williams PL.

AIDS. 2007 May 31;21(9):1109-17.

PMID:
17502721
18.

Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users.

Boccellari AA, Chambers DB, Dilley JW, Shore MD, Tauber MA, Moss AR, Osmond DH.

J Acquir Immune Defic Syndr. 1994 Oct;7(10):1040-9.

PMID:
7916050
19.

Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.

Storm DS, Boland MG, Gortmaker SL, He Y, Skurnick J, Howland L, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Study Team.

Pediatrics. 2005 Feb;115(2):e173-82. Epub 2005 Jan 3.

PMID:
15629958
20.

Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women.

Richardson JL, Nowicki M, Danley K, Martin EM, Cohen MH, Gonzalez R, Vassileva J, Levine AM.

AIDS. 2005 Oct 14;19(15):1659-67.

PMID:
16184036

Supplemental Content

Support Center